BioNTech
BNTX
BNTX
295 hedge funds and large institutions have $5.24B invested in BioNTech in 2024 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 75 increasing their positions, 93 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% more funds holding
Funds holding: 284 → 295 (+11)
1.36% more ownership
Funds ownership: 17.25% → 18.6% (+1.4%)
19% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 93
Holders
295
Holding in Top 10
7
Calls
$367M
Puts
$317M
Top Buyers
| 1 | +$515M | |
| 2 | +$67.3M | |
| 3 | +$46M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$32M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$25.6M |
Top Sellers
| 1 | -$269M | |
| 2 | -$76.8M | |
| 3 | -$57.9M | |
| 4 |
Morgan Stanley
New York
|
-$43.4M |
| 5 |
DM
Deerfield Management
New York
|
-$38.6M |